Janux Therapeutics Inc

NASDAQ:JANX  
11.68
+0.68 (+6.18%)
Earnings Announcements

Janux Therapeutics Reports First Quarter 2022 Results And Business Highlights

Published: 05/10/2022 21:05 GMT
Janux Therapeutics Inc (JANX) - Janux Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights.
Janux Therapeutics Inc - Qtrly Loss per Share $0.32.
Janux Therapeutics Inc - Qtrly Collaboration Revenue $1.6 Million Versus $380,000.
Revenue is expected to be $0.85 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0.82 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.